Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 676.80
Bid: 678.10
Ask: 678.30
Change: 3.60 (0.53%)
Spread: 0.20 (0.029%)
Open: 678.60
High: 679.40
Low: 670.30
Prev. Close: 673.20
HSBA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report - 29 of 54

20 Mar 2015 16:43

RNS Number : 0441I
HSBC Holdings PLC
20 March 2015
 



The above tables analyse loans and advances by industry sector and by the location of the principal operations of the lending subsidiary or, in the case of the operations of The Hongkong and Shanghai Banking Corporation, HSBC Bank, HSBC Bank Middle East and HSBC Bank USA, by the location of the lending branch.

HSBC Holdings

(Audited)

Risk in HSBC Holdings is overseen by the HSBC Holdings Asset and Liability Management Committee ('HALCO'). The major risks faced by HSBC Holdings are credit risk, liquidity risk and market risk (in the form of interest rate risk and foreign exchange risk), of which the most significant is credit risk.

Credit risk in HSBC Holdings primarily arises from transactions with Group subsidiaries and from guarantees issued in support of obligations assumed by certain Group operations in the normal conduct of their business. It is reviewed and managed within regulatory and internal limits for exposures by our Global Risk function, which provides high-level centralised oversight and management of credit risks worldwide.

HSBC Holdings' maximum exposure to credit risk at 31 December 2014 is shown below. Its financial assets principally represent claims on Group subsidiaries in Europe and North America.

All the derivative transactions are with HSBC undertakings that are banking counterparties (2013: 100%) and for which HSBC Holdings has in place master netting arrangements. Since 2012, the credit risk exposure has been managed on a net basis and the remaining net exposure is specifically collateralised in the form of cash.

 

HSBC Holdings - maximum exposure to credit risk

(Audited)

2014

2013

Maximumexposure

Offset

Exposure tocredit risk(net)

Maximumexposure

Offset

Exposure tocredit risk(net)

US$m

US$m

US$m

US$m

US$m

US$m

Cash at bank and in hand:

- balances with HSBC undertakings

249

-

249

407

-

407

Derivatives

2,771

(2,610)

161

2,789

(2,755)

34

Loans and advances to HSBC undertakings

43,910

-

43,910

53,344

-

53,344

Financial investments in HSBC undertakings

4,073

-

4,073

1,210

-

1,210

Financial guarantees and similar contracts

52,023

-

52,023

52,836

-

52,836

Loan and other credit-related commitments

16

-

16

1,245

-

1,245

At 31 December

103,042

(2,610)

100,432

111,831

(2,755)

109,076

 

The credit quality of loans and advances and financial investments, both of which consist of intra-Group lending, is assessed as 'strong' or 'good', with 100% of the exposure being neither past due nor impaired (2013: 100%).

Securitisation exposures and other structured products

(Audited)

This section contains information about our exposure to asset-backed securities ('ABS's), some of which are held through consolidated structured entities and are summarised in the table below.

A summary of the nature of HSBC's exposures is provided in the Appendix to Risk on page 214.

 

Overall exposure of HSBC

(Audited)

Carrying amount23

2014

2013

US$bn

US$bn

Asset-backed securities

48.9

50.1

- fair value through profit or loss

3.6

3.1

- available for sale24

29.7

42.7

- held to maturity24

13.4

1.1

- loans and receivables

2.2

3.2

At 31 December

48.9

50.2

For footnotes, see page 202.

The following table summarises the carrying amount of our ABS exposure by categories of collateral and includes assets held in the GB&M legacy credit portfolio with a carrying value of US$23bn (2013: US$28bn).

At 31 December 2014, the available-for-sale reserve in respect of ABSs was a deficit of US$777m (2013: deficit of US$1,643m). For 2014, the impairment write-back in respect of ABSs was US$276m (2013: write-back of US$289m).

Carrying amount of HSBC's consolidated holdings of ABSs23

(Audited)

Trading

Available for sale

Held to maturity

Designated at fair value throughprofit or loss

Loans and receivables

Total

Of which

held through

consolidated

SEs

US$m

US$m

US$m

US$m

US$m

US$m

US$m

Mortgage-related assets:

Sub-prime residential

122

3,081

-

-

308

3,511

2,075

US Alt-A residential

96

3,022

11

-

110

3,239

2,411

US Government agency and sponsored enterprises:

MBSs

82

10,401

13,436

-

-

23,919

-

Other residential

928

1,220

-

-

330

2,478

652

Commercial property

654

3,627

-

-

516

4,797

2,854

Leveraged finance-related assets

172

3,660

-

-

218

4,050

2,526

Student loan-related assets

242

3,545

-

-

119

3,906

3,284

Other assets

1,264

1,114

-

19

646

3,043

758

At 31 December 2014

3,560

29,670

13,447

19

2,247

48,943

14,560

Mortgage-related assets:

Sub-prime residential

178

2,977

-

-

403

3,558

2,782

US Alt-A residential

101

3,538

18

-

134

3,791

2,926

US Government agency and sponsored enterprises:

MBSs

178

18,661

1,110

-

-

19,949

-

Other residential

618

1,925

-

-

399

2,942

1,513

Commercial property

133

5,667

-

104

669

6,573

5,146

Leveraged finance-related assets

294

5,011

-

-

251

5,556

4,310

Student loan-related assets

196

3,705

-

-

121

4,022

3,495

Other assets

1,271

1,265

-

34

1,186

3,756

989

At 31 December 2013

2,969

42,749

1,128

138

3,163

50,147

21,161

For footnote, see page 202.

 

Representations and warranties related to mortgage sales and securitisation activities

(Unaudited)

We have been involved in various activities related to the sale and securitisation of residential mortgages that are not recognised on our balance sheet. These activities include:

· the purchase of US$24bn of third-party originated mortgages by HSBC Bank USA and their securitisation by HSBC Securities (USA) Inc. ('HSI') between 2005 and 2007;

· HSI acting as underwriter for the third-party issuance of private label mortgage-backed securities ('MBS's) with an original issuance value of US$37bn, most of which were sub-prime; and

· the origination and sale by HSBC Bank USA of mortgage loans, primarily to government-sponsored entities.

In selling and securitising mortgage loans, various representations and warranties may be made to purchasers of the mortgage loans and MBSs. When purchasing and securitising mortgages originated by third parties and underwriting third-party MBSs, the obligation to repurchase loans in the event of a breach of loan level representations and warranties resides predominantly with the organisation that originated the loan.

Participants in the US mortgage securitisation market that purchased and repackaged whole loans, such as servicers, originators, underwriters, trustees or sponsors of securitisations, have been the subject of lawsuits and governmental and regulatory investigations and inquiries.

At 31 December 2014, a liability of US$27m (2013: US$99m) was recognised in respect of various representations and warranties regarding the origination and sale by HSBC Bank USA of mortgage loans, primarily to government sponsored entities. These relate to, among other things, the ownership of the loans, the validity of the liens, the loan selection and origination process and compliance with the origination criteria established by the agencies. In the event of a breach of its representations and warranties, HSBC Bank USA may be obliged to repurchase the loans with identified defects or to indemnify the buyers. The estimated liability was based on the level of outstanding repurchase demands, the level of outstanding requests for loan files and the expected future repurchase demands in respect of mortgages sold to date which were either two or more payments delinquent or might become delinquent at an estimated conversion rate. Repurchase demands of US$3m were outstanding at 2014 (2013: US$44m).

For further information on legal proceedings and regulatory matters, see Note 40 on the Financial Statements.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACSURVARVOAOUAR
Date   Source Headline
14th Jun 20245:20 pmRNSTransaction in Own Shares
14th Jun 202411:00 amRNSIssuance of contingent convertible securities
13th Jun 20245:30 pmRNSTransaction in Own Shares
13th Jun 20247:00 amRNSIssuance of contingent convertible securities
12th Jun 20245:24 pmRNSTransaction in Own Shares
11th Jun 20245:38 pmRNSTransaction in Own Shares
11th Jun 20241:00 pmRNSFirst Interim and Special Dividend - Exchange Rate
10th Jun 20245:15 pmRNSTransaction in Own Shares
7th Jun 20245:32 pmRNSTransaction in Own Shares
6th Jun 20245:16 pmRNSTransaction in Own Shares
5th Jun 20245:44 pmRNSTransaction in Own Shares
4th Jun 20245:22 pmRNSTransaction in Own Shares
3rd Jun 20245:12 pmRNSTransaction in Own Shares
31st May 20245:23 pmRNSTransaction in Own Shares
31st May 20244:30 pmRNSTotal Voting Rights
30th May 20245:28 pmRNSTransaction in Own Shares
29th May 20245:28 pmRNSTransaction in Own Shares
29th May 20244:30 pmRNSDirector/PDMR Shareholding
28th May 20245:27 pmRNSTransaction in Own Shares
28th May 20247:00 amRNSTransaction in Own Shares
24th May 20245:38 pmRNSTransaction in Own Shares
23rd May 20245:30 pmRNSTransaction in Own Shares
22nd May 20245:23 pmRNSTransaction in Own Shares
21st May 20245:25 pmRNSTransaction in Own Shares
20th May 20245:34 pmRNSTransaction in Own Shares
20th May 20243:06 pmRNSIssuance of senior unsecured notes
17th May 20245:32 pmRNSTransaction in Own Shares
17th May 20242:30 pmRNSIssuance of senior unsecured notes
16th May 20245:23 pmRNSTransaction in Own Shares
15th May 20245:40 pmRNSTransaction in Own Shares
15th May 202411:00 amRNSResults of tender offers for four series of notes
14th May 20245:55 pmRNSPricing terms for tender offers for notes
14th May 20245:54 pmRNSTransaction in Own Shares
14th May 20248:52 amRNSHolding(s) in Company
13th May 20245:30 pmRNSTransaction in Own Shares
13th May 20249:23 amRNSHolding(s) in Company
13th May 20249:16 amRNSPre Stabilisation Notice
10th May 20245:28 pmRNSTransaction in Own Shares
10th May 202410:01 amRNSDirector/PDMR Shareholding
10th May 202410:00 amRNSOverseas Regulatory Announcement - Grant of Awards
10th May 20249:03 amRNSHolding(s) in Company
9th May 20245:36 pmRNSTransaction in Own Shares
8th May 20245:40 pmRNSTransaction in Own Shares
8th May 20247:00 amRNSHSBC tender offers for four series of notes
7th May 202410:30 amRNSHSBC Holdings plc – Share buy-back
3rd May 20243:20 pmRNSAGM poll results + changes Board+Ctte composition
3rd May 202411:06 amRNSHSBC Holdings plc - AGM Statements
1st May 20244:30 pmRNSDirector Declaration
1st May 20244:00 pmRNSPublication of base prospectus supplement
30th Apr 20244:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.